CRWV heads into its August 6 earnings window with a busy week of analyst activity pulling in opposite directions — upgrades and new coverage on one side, target-price cuts across the board on the other — while shorts continue their slow retreat from July's extreme.
The Street moved fast this week, and the message was mixed. Truist upgraded CRWV to Buy even while trimming its target to $126. Baird initiated at Outperform with a $100 target. Barclays held its Equal-Weight rating but slashed its target from $120 to $90 — a 25% cut that landed the same day as a Jefferies reduction from $160 to $150, with the Buy rating intact. Mizuho and Macquarie made similar moves last week: both kept positive-leaning ratings while trimming targets. The direction of travel is clear — the Street still broadly likes the story but is resetting price anchors lower. The consensus sits at Buy with a mean target around $140, roughly 76% above Tuesday's close of $79.58. That gap is wide enough to be an anchor rather than a near-term catalyst. The bull case rests on the $125bn projected backlog and AI infrastructure scarcity; the bear case flags extreme leverage, customer concentration, and the risk that AI demand commercialises slower than the business plan assumes.
Short positioning has continued to ease, building on last week's picture. Short interest dipped another 1.5% on Tuesday to 22.98% of free float — approximately 88.8 million shares — down from the July 7-9 peak above 105 million but still elevated versus the low-60-million base that prevailed through most of June. The one-month change remains stark: shorts have grown 45% in 30 days. Borrow conditions are not adding pressure. Cost to borrow is running at roughly 0.52%, up about 6% on the week but still low in absolute terms. Availability has loosened to 224% — more than two shares available to borrow for every one already lent out — a meaningful improvement from the 176% reading seen on July 8 when the short position was at its heaviest. That combination of high short interest and relaxed borrow conditions puts CRWV in a curious spot: the bear position is large, but new shorts face no friction adding to it. Options are equally calm. The put/call ratio is 0.79, slightly below its 20-day average of 0.81 and well within one standard deviation of normal, suggesting no particular urgency in either direction from derivatives traders. The ORTEX short score has eased from 65.9 on July 8 to 63.6 today — still elevated, but trending softer alongside the declining short position.
The CEO's activity warrants a note. Founder and chief executive Michael Intrator sold approximately 265,000 shares on July 14 in a series of transactions totalling roughly $21.6 million, at prices between $79 and $86. His reported holding subsequently dropped to 54.8 million shares — still 10% of the company. The sales came as the stock traded in its current range, which at first glance looks like supply-side pressure near a key technical level. Co-founders Brian Venturo and Brannin McBee also reduced holdings recently, with Venturo cutting 7.2 million shares and McBee trimming 2.1 million. None of the transactions carry a high significance score, and the 90-day net insider position is actually slightly positive at around 406,000 shares. The pattern looks more like systematic distribution — likely a post-IPO lockup cadence — than a directional call, but the volume is worth tracking in context of the stock's 33% one-month decline.
CRWV has reported twice since listing. The May 7 print produced a sharp one-day drop of 17% with losses extending through the subsequent week. The June 8 release was far more contained — down less than 2% on the day before recovering 6% over the following five sessions. Two data points are too few for a firm pattern, but the contrast in reactions suggests the market is still calibrating what "good" looks like for this business. With the next print on August 6, the stock enters the window down 32% from a month ago and trading well below where most analysts have their targets.
Closest peer APLD gained 7.9% on Tuesday and is up 5.5% on the week, outperforming CRWV's flat weekly performance. The divergence may reflect APLD's simpler capital structure attracting capital that has rotated away from more leveraged AI infrastructure names. The degree to which CRWV can close that performance gap before August 6 will likely depend on whether the ongoing short reduction accelerates — or stalls — as earnings approach.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
